Choosing lipid lowering statin in risk strategy of cardiovascular event prevention

Aim. To investigate low density lipoprotein cholesterol (LDL-CH) lowering effectiveness of atorvastatin (Torvacard; 20 mg/d) in patients with moderate hypercholesterolemia (HCH) after 4 and 12 weeks of treatment, together with standard hypolipidemic diet; to assess (%) target LDL-CH level achievemen...

Full description

Bibliographic Details
Main Authors: A. Ya. Yvleva, L. A. Alekseeva, N. M. Poluboyarova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2007-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1144